Kyushu University Academic Staff Educational and Research Activities Database
Search by Keyword How ro search
Keyword
Search Criteria
 
Detailed Search

Researcher information (To researchers) Need Help? How to update
Atsunobu Takeda Last modified date：2022.07.04

Associate Professor / Department of Ophthalmology, Graduate School of Medical Sciences
Department of Clinical Medicine
Faculty of Medical Sciences


Graduate School
Department of Integrative Biomedical Sciences
Graduate School of Medical Sciences
Department of Health Sciences
Graduate School of Medical Sciences
Undergraduate School
Department of Medicine
School of Medicine
Other Organization
Research Center for Education in Health Care System


E-Mail　*Since the e-mail address is not displayed in Internet Explorer, please use another web browser:Google Chrome, safari.
Homepage
https://kyushu-u.pure.elsevier.com/en/persons/atsunobu-takeda
　Reseacher Profiling Tool　Kyushu University Pure
Phone
092-642-5648
Fax
092-642-5663
Academic Degree
MD, PhD
Country of degree conferring institution (Overseas)
Yes　Doctor
Field of Specialization
Ophthalmology
Total Priod of education and research career in the foreign country
02years01months
Research
Research Interests
  • Elucidation of regulatory mechanisms of uveitic and diabetic macular edema
    keyword : uveitis, diabetic retinopathy, macular edema
    2021.10～2025.03.
  • Elucidation of the pathogenesis of vitreoretinal lymphoma
    keyword : vitreoretinal lymphoma, diffuse large B-cell lymphoma
    2015.05～2025.05.
  • Clinical and basic research for uveitis
    Elucidation of the pathogenesis of choroidal neovascular diseases
    keyword : Ophthalmology, Uveitis, Choroidal neovascular diseases, Ocular immunology, Ocular inflammation
    2012.09～2018.03.
  • Suppression of subretinal fibrosis due to choroidal neovascularization
    keyword : age-related macular degeneration, choroidal neovascularization, innate immunity, cytokine
    2010.10～2013.03.
Academic Activities
Books
 Show All Books >>
1. Takeda A, Arima M, Ishikawa K, Hasegawa E, Murakami Y, Sonoda KH, Acute Retinal Necrosis and Progressive Outer Retinal Necrosis, Inflammatory and Infectious Ocular Disorders　2019:215-220, 2021.05.
Reports
 Show All Reports >>
1. Hasegawa E, Takeda A, Yawata N, Sonoda KH, The effectiveness of adalimumab treatment for non-infections uveitis., Immunol Med., 2019.06.
2. Takeda A, Sonoda KH, Ishibashi T, Epidemiology of Uveitis, Caused by HTLV-1, Toxoplasmosis, and Tuberculosis; The Three Leading Causes of Endemic Infectious Uveitis in Japan., Ocul Immunol Inflamm., 2017.12.
3. Atsunobu Takeda, Koh-hei Sonoda, Tatsuro Ishibashi, Regulation of Th1 and Th17 cell differentiation in uveitis, Inflammation and Regeneration, 2013.11.
Papers
 Show All Papers >>
1. Takeda A, Hasegawa E, Yawata N, Notomi S, Ishikawa K, Murakami Y, Hisatomi T, Kimura K, Sonoda KH, Increased vitreous levels of B cell activation factor (BAFF) and soluble interleukin-6 receptor in patients with macular edema due to uveitis related to Behçet’s disease and sarcoidosis, Graefe’s Arch Clin Exp Opthalmol., 10.1007/s00417-022-05600-1., 2022.03.
2. Takeda A, Hasegawa E, Notomi S, Ishikawa K, Arima M, Murakami Y, Nakao S, Hisatomi T, Sonoda KH, Surgical Outcomes of Contrast Sensitivity and Visual Acuity in Uveitis-Associated Cataract, Clincal Ophthalmology, 10.2147/OPTH.S314173, 15, 2665-2673, 2021.06.
3. Takeda A, Hasegawa E, Nakao S, Ishikawa K, Murakami Y, Hisatomi T, Arima M, Yawata N, Oda Y, Kimura K, Yoshikawa H, Sonoda KH., Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma, Scientific Reports, 10.1038/s41598-020-72962-z , 10, 1, 15715, 2020.09.
4. Ito T, Takeda A, Fujiwara K, Hasegawa E, Nakao S, Ohishi Y, Oda Y, Yoshikawa H, Sonoda KH., Risk factors for failure of vitrectomy cell block technique in cytological diagnosis of vitreoretinal lymphoma., Graefe’s Arch Clin Exp Opthalmol., 257, 5, 1029-1036, 2019.05.
5. Takeda A, Yamada H, Hasegawa E, Arima M, Notomi N, Myojin S, Yoshimura T, Hisatomi T, Enaida H, Yanai R, Kimura K, Ishibashi T, Sonoda KH., Crucial role of P2X7 receptor for effector T cell activation in experimental autoimmune uveitis., Jpn J Ophthalmol., 62, 3, 398-406, 2018.05.
6. Sato K, Takeda A, Hasegawa E, Jo YJ, Arima M, Oshima Y, Yanai R, Nakazawa T, Yuzawa M, Nakashizuka H, Shimada H, Kimura K, Ishibashi T, Sonoda KH., Interleukin-6 plays a crucial role in the development of subretinal fibrosis in a mouse model., Immunological Medicine, 41, 1, 23-29, 2018.01.
7. Taki R, Takeda A, Yoshikawa H, Fukuhara T, Arita R, Suehiro Y, Che I, Kumano Y, Nakamura T, Ishibashi T, Clinical features of systemic metastatic retinal lymphoma in Japanese patients., Ocul Immunol Inflamm., 25, 5, 654-662, 2017.10.
8. Takeda A, Yoshikawa H, Fukuhara T, Hikita S, Otomo T, Arita R, Oshima Y, Hisatomi T, Kimura K, Yoshida S, Kawano Y, Sonoda KH, Ishibashi T, Distinct profiles of soluble cytokine receptors between B-cell vitreoretinal lymphoma and uveitis, Invest Ophthalmol Vis Sci., 56, 12, 7516-7523, 2015.12.
9. Takeda A, Hasegawa E, Fukuhara T, Hirakawa S, Yamada H, Yang Y, Yoshimura T, Hisatomi T, Oshima Y, Yoshida H, Sonoda KH, Ishibashi T, EBI3 is pivotal for the initiation of experimental autoimmune uveitis., Experimental Eye Research, doi: 10.1016/j.exer.2014.06.004., 125, 107-113, 2014.08.
10. Yang Y, Takeda A, Yoshimura T, Oshima Y, Sonoda KH, Ishibashi T, IL-10 is significantly involved in HSP70-regulation of experimental subretinal fibrosis, Plos one, 8, 12, e80288, 2013.12.
11. Hasegawa E, Oshima Y, Takeda A, Saeki K, Yoshida H, Sonoda KH, Ishibashi T., IL-27 inhibits pathological ocular neovascularization due to laser burn., J Leukoc Biol, 22045869, 91, 2, 267-273, 2012.02.
12. Takeda A, Baffi JZ, Kleinman ME, Cho W, Nozaki M, Yamada K, Kaneko H, Albuquerque RJC, Dridi S, Saito K, Raisler BJ, Budd SJ, Geisen P, Munitz A, Ambati BK, Rich MG, Ishibashi T, Wright JD, Humbles AA, Gerard CJ, Ogura Y, Pan Y, Smith JR, Grisanti S, Hartnett ME, Rothenberg ME, Ambati J., CCR3 is a therapeutic and diagnostic non-inflammatory target for neovascular age-related macular degeneration, Nature, 460, 7252, 225-230, 2009.07.
13. Kleinman ME*, Yamada K*, Takeda A*, Chandrasekaren V, Nozaki M, Baffi JZ, Albuquerque RJC, Yamasaki S, Itaya M, Pan Y, Appukutan B, Gibbs D, Yang Z, Kariko K, Ambati BK, Wilgus TA, DiPietro LA, Sakurai E, Zhang K, Smith JR, Taylor EW, Ambati J., Sequence- and target-independent suppression of angiogenesis by siRNA via TLR3, Nature, 452, 7187, 591-597, 2008.03.
14. Ambati BK, Nozaki M*, Singh N*, Takeda A*, Jani PD*, Suthar T, Albuquerque RJC, Richter E, Sakurai E, Newcomb MT, Kleinman ME, Caldwell RB, Lin Q, Ogura Y, Orecchia A, Samuelson DA, Agnew DW, Leger JS, Green WR, Mahasreshti PJ, Curiel DT, Kwan D, Marsh H, Ikeda S, Leiper LJ, Collinson JM, Bogdanovich S, Khurana TS, Shibuya M, Baldwin ME, Ferrara N, Gerber HP, De Falco S, Witta J*, Baffi JZ*, Raisler BJ*, Ambati J., Corneal avascularity is due to soluble VEGF receptor-1, Nature, 443, 7114, 993-997, 2006.10.
15. Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, Yoshimura A, Yoshida H, Two-sided roles of IL-27; induction of Th1 differentiation on naïve CD4+ T cells vs. suppression of pro-inflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism., J Immunol , 177, 8, 5377-5385, 2006.08.
16. Takeda A, Hamano S, Shiraishi H, Yoshimura T, Ogata H, Ishii K, Ishibashi T, Yoshimura A, Yoshida H., Hyperproliferation and hyperproduction of cytokines by WSX-1-overexpressing CD4+ T cells in response to TCR stimulation, Int Immunol, 17, 7, 889-897, 2005.07.
17. Takeda A, Hata Y, Shiose S, Sassa Y, Honda M, Fujisawa K, Sakamoto T, Ishibashi T., Suppression of experimental choroidal neovascularization utilizing KDR selective receptor tyrosine kinase inhibitor, Graefe’s Arch Clin Exp Opthalmol, 10.1007/s00417-003-0688-7, 241, 9, 765-772, 2003.09.
18. Takeda A, Hamano S, Yamanaka A, Hanada T, Ishibashi T, Mak TW, Yoshimura A, Yoshida H., Role of IL-27/WSX-1 signaling for induction of T-bet through activation of STAT1 during initial Th1 commitment., J Immunol, 170, 10, 4886-4890, 2003.05.
Presentations
 Show All Presentations >>
1. Takeda A, Hasegawa E, Nakao S, Ishikawa K, Murakami Y, Hisatomi T, Arima M, Yawata N, Oda Y, Kimura K, Yoshikawa H, Sonoda KH., Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma., The 59th Annual Meeting of Japanese Retina and Vitreous Society, 2020.12.
2. Takeda A, Hasegawa E, Nakao S, Ishikawa K, Murakami Y, Hisatomi T, Arima M, Yawata N, Oda Y, Kimura K, Yoshikawa H, Sonoda KH., Vitreous levels of interleukin-35 as a prognostic factor in B-cell vitreoretinal lymphoma., 2020.12.
3. Takeda A, Yoshikawa H, Arita R, Hisatomi T, Kimura K, Yoshida S, Kawano Y, Ishibashi T, Sonoda KH, Distinct profiles of soluble cytokine receptors between B-cell vitreoretinal lymphoma and uveitis., The 14th International Ocular Inflammation Society Meeting,, 2017.10.
4. Atsunobu Takeda, Takeru Yoshimura, Sayaka Hirakawa, Toshio Hisatomi, Yasuhiro Ikeda, Hiroshi Enaida, Yuji Oshima, Koh-hei Sonoda, Tatsuro Ishibashi, Pivotal roles of P2RX7 in the induction of Th1 and Th17 responses in experimental autoimmune uveitis, The Association for Research in Vision and Ophthalmology 2014, 2014.05.
5. Atsunobu Takeda, Takako Fukuhara, Kuniaki Hijioka, Koh-hei Sonoda, Tatsuro Ishibashi, Long-term efficacy of infliximab maintenance therapy in refractory uveitis of Behcet’s disease at Kyushu University Hospital: a 24-month follow-up study, World Ophthalmology Congress 2014, 2014.04.
6. Atsunobu Takeda, Takako Fukuhara, Kuniaki Hijioka, Shinichi Hikita, Takeru Yoshimura, Mitsuteru Akahoshi, Hiroaki Niiro, Hiroshi Tsukamoto, Takahiko Horiuchi, Yoichi Kawano, Koh-hei Sonoda, Tatsuro Ishibashi, Long-term efficacy of infliximab maintenance therapy in refractory uveitis of Behcet’s disease at Kyushu University Hospital: a 24-month follow-up study., The 6th joint meeting of China- Japan-Korea Ophthalmologists, 2013.09.
7. Atsunobu Takeda, Toshio Hisatomi, Yasuhiro Ikeda, Koh-Hei Sonoda, tatsuro ishibashi, Pivotal roles of EBI3 for the initiation and maintenance of experimental autoimmune uveitis., The Association for Research in Vision and Ophthalmology 2013, 2013.05.
8. Atsunobu Takeda, Hiroshi Tsukamoto, Hiroaki Niiro, tatsuro ishibashi, Serum Infliximab levels, baseline TNF-alpha, and the effectiveness of Infliximab therapy for uveitis in Behcet's disease., The 5th joint meeting of Japan-china-Koreaophthalmologists, 2012.11.
9. Atsunobu Takeda, Koh-hei Sonoda, Takeru Yoshimura, Toshio Hisatomi, Yasuhiro Ikeda, Hiroshi Enaida, Tatsuro Ishibashi, Pivotal roles of P2X7 in the induction of Th1 and Th17 responses in experimental autoimmune uveitis, World Ophthalmology Congress 2012, 2012.02.
Membership in Academic Society
  • International Ocular Inflammation Society
  • The International Ocular Inflammation Society
  • Japanese Retina and Vitreous Society
  • The Japanese Society of Clinical Immunology
  • The Association for Research in Vision and Ophthalmology (ARVO)
  • Japanese Society for Immunology
  • Japanese Ocular Inflammation Society
  • Japan Ophthalmologists Association
  • Japanese Ophtalmological Society
Educational
Other Educational Activities
  • 2010.12.


Unauthorized reprint of the contents of this database is prohibited.

Copyright © 2006, Kyushu University. All rights reserved.